Kenichiro Kudo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kenichiro Kudo has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Mitsune Tanimoto
Department of Respiratory Medicine, Iwakuni Clinical Center, Japan
2 shared publications- Akihiko Taniguchi
Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan
1 shared publication Akiko Hisamoto
Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan
1 shared publicationEiki Ichihara
Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan
1 shared publication- Eiki Ichihara
Center for Clinical Oncology, Okayama University Hospital, Okayama, Japan
1 shared publication - Eiki Ichihara
Okayama University Hospital
1 shared publication
Latest Publications
- Open Access
- 28 March 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Bronchoscopic removal of lower airway foreign body: a two-center retrospective cohort study
Background: Tracheobronchial foreign body (FB) aspiration is a life-threatening condition, particularly in older adults. Despite its clinical significance, research on the etiology of adult FB aspiration, as well as real-world outcomes and complications associated with FB removal in lower airways, remains limited. Patients and methods: This was a two-center retrospective cohort study in Japan. We included adult patients aged 18 years or older who underwent bronchoscopic FB removal between April 2010 and March 2025. Results: A total of 28 patients were included in this analysis (mean age, 75.4 years [median age: 75 years]; range, 55–102 years). Nineteen patients (67.9%) were male. The most frequently reported symptoms were coughing (46.4%), sputum production (39.3%), and dyspnea (17.9%). A total of 30 FBs were identified, with dental prostheses (60.0%) being the most common type, followed by natural teeth (10.0%). FBs were slightly more common on the right side (53.3%) than on the left side (43.3%), with the right lower lobe being the most frequent site of lodgement (30.0%), followed by the left lower lobe (20.7%). The most frequently bronchoscopic findings were mucosal edema (36.7%) and bleeding (26.7%). FB removal was performed using flexible bronchoscopy in 26 patients (92.9), with the exception of two cases (7.1%) in which rigid bronchoscopy was employed. Bronchoscopy was performed in the endoscopy room for 21 patients (75.0%). Among the 28 patients, standard forceps were used in 24 (85.7%), followed by basket forceps, which was employed in 10 patients (35.7%). FB removal was successful in 26 (92.9%) patients. Regarding adverse events, hypoxia was the only complication observed, occurring in 18 patients (64.3%); no other adverse events were reported. Conclusions: Most FB in the lower airways can be successfully and safely removed via flexible bronchoscopy.
- 28 March 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Open AccessBronchoscopic removal of lower airway foreign body: a two-center retrospective cohort study
Background: Tracheobronchial foreign body (FB) aspiration is a life-threatening condition, particularly in older adults. Despite its clinical significance, research on the etiology of adult FB aspiration, as well as real-world outcomes and complications associated with FB removal in lower airways, remains limited. Patients and methods: This was a two-center retrospective cohort study in Japan. We included adult patients aged 18 years or older who underwent bronchoscopic FB removal between April 2010 and March 2025. Results: A total of 28 patients were included in this analysis (mean age, 75.4 years [median age: 75 years]; range, 55–102 years). Nineteen patients (67.9%) were male. The most frequently reported symptoms were coughing (46.4%), sputum production (39.3%), and dyspnea (17.9%). A total of 30 FBs were identified, with dental prostheses (60.0%) being the most common type, followed by natural teeth (10.0%). FBs were slightly more common on the right side (53.3%) than on the left side (43.3%), with the right lower lobe being the most frequent site of lodgement (30.0%), followed by the left lower lobe (20.7%). The most frequently bronchoscopic findings were mucosal edema (36.7%) and bleeding (26.7%). FB removal was performed using flexible bronchoscopy in 26 patients (92.9), with the exception of two cases (7.1%) in which rigid bronchoscopy was employed. Bronchoscopy was performed in the endoscopy room for 21 patients (75.0%). Among the 28 patients, standard forceps were used in 24 (85.7%), followed by basket forceps, which was employed in 10 patients (35.7%). FB removal was successful in 26 (92.9%) patients. Regarding adverse events, hypoxia was the only complication observed, occurring in 18 patients (64.3%); no other adverse events were reported. Conclusions: Most FB in the lower airways can be successfully and safely removed via flexible bronchoscopy.
- Open Access
- 31 July 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (15) , 8370
Increased Oxidative Stress and Decreased Citrulline in Blood Associated with Severe Novel Coronavirus Pneumonia in Adult Patients
This study investigated the correlation between oxidative stress and blood amino acids associated with nitric oxide metabolism in adult patients with coronavirus disease (COVID-19) pneumonia. Clinical data and serum samples were prospectively collected from 100 adult patients hospitalized for COVID-19 between July 2020 and August 2021. Patients with COVID-19 were categorized into three groups for analysis based on lung infiltrates, oxygen inhalation upon admission, and the initiation of oxygen therapy after admission. Blood data, oxidative stress-related biomarkers, and serum amino acid levels upon admission were compared in these groups. Patients with lung infiltrations requiring oxygen therapy upon admission or starting oxygen post-admission exhibited higher serum levels of hydroperoxides and lower levels of citrulline compared to the control group. No remarkable differences were observed in nitrite/nitrate, asymmetric dimethylarginine, and arginine levels. Serum citrulline levels correlated significantly with serum lactate dehydrogenase and C-reactive protein levels. A significant negative correlation was found between serum levels of citrulline and hydroperoxides. Levels of hydroperoxides decreased, and citrulline levels increased during the recovery period compared to admission. Patients with COVID-19 with extensive pneumonia or poor oxygenation showed increased oxidative stress and reduced citrulline levels in the blood compared to those with fewer pulmonary complications. These findings suggest that combined oxidative stress and abnormal citrulline metabolism may play a role in the pathogenesis of COVID-19 pneumonia.
- 31 July 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (15) , 8370
Open AccessIncreased Oxidative Stress and Decreased Citrulline in Blood Associated with Severe Novel Coronavirus Pneumonia in Adult Patients
This study investigated the correlation between oxidative stress and blood amino acids associated with nitric oxide metabolism in adult patients with coronavirus disease (COVID-19) pneumonia. Clinical data and serum samples were prospectively collected from 100 adult patients hospitalized for COVID-19 between July 2020 and August 2021. Patients with COVID-19 were categorized into three groups for analysis based on lung infiltrates, oxygen inhalation upon admission, and the initiation of oxygen therapy after admission. Blood data, oxidative stress-related biomarkers, and serum amino acid levels upon admission were compared in these groups. Patients with lung infiltrations requiring oxygen therapy upon admission or starting oxygen post-admission exhibited higher serum levels of hydroperoxides and lower levels of citrulline compared to the control group. No remarkable differences were observed in nitrite/nitrate, asymmetric dimethylarginine, and arginine levels. Serum citrulline levels correlated significantly with serum lactate dehydrogenase and C-reactive protein levels. A significant negative correlation was found between serum levels of citrulline and hydroperoxides. Levels of hydroperoxides decreased, and citrulline levels increased during the recovery period compared to admission. Patients with COVID-19 with extensive pneumonia or poor oxygenation showed increased oxidative stress and reduced citrulline levels in the blood compared to those with fewer pulmonary complications. These findings suggest that combined oxidative stress and abnormal citrulline metabolism may play a role in the pathogenesis of COVID-19 pneumonia.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA5151
Clinical study of AERO stent placement for malignant airway stenosis in Okayama Medical Center
Purpose: We clinically investigated cases in which an AERO stent was placed for airway stenosis due to malignant disease at our hospital. Subjects: Twenty-two patients who underwent AERO stent placement between October 2016 and March 2022 were included. The age distribution ranged from 52 to 89 years old, 16 males and 6 females. Causes of airway stenosis were lung cancer in 11 cases, esophageal cancer in 4 cases, thyroid cancer in 3 cases, breast cancer in 2 cases, prostate cancer in 1 case, and mediastinal tumor in 1 case. 13 cases were placed under a rigid endoscope, and 9 cases were placed under a flexible endoscope. Post-treatment was performed in 15 cases, including chemotherapy alone in 7 cases, radiotherapy alone in 5 cases, and chemoradiotherapy in 3 cases. Postoperative dyspnea improved in all patients. Postoperative complications included 2 cases of infection (1 case of cervical abscess, 1 case of pneumonia), 2 cases of prolapse, 2 cases of esophageal obstruction, and 1 case of reintubation after weaning the ventilator after surgery. There were no cases where ECMO was attached, and only sheath insertion was performed in 3 cases. The median survival time for all patients was 79.5 days, with a median survival time of 100 days (36-449 days) in the post-treatment group and 74 days (18-210 days) in the no-treatment group. Long-term survival trended (p=0.064) in the post-treatment group. Conclusion: Although stent treatment for airway stenosis is a palliative treatment, it greatly contributes to QOL improvement. In stenosis caused by malignant tumors, prolongation of survival can be expected by performing post-treatment such as chemotherapy and radiotherapy after stent placement.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA5151
Clinical study of AERO stent placement for malignant airway stenosis in Okayama Medical Center
Purpose: We clinically investigated cases in which an AERO stent was placed for airway stenosis due to malignant disease at our hospital. Subjects: Twenty-two patients who underwent AERO stent placement between October 2016 and March 2022 were included. The age distribution ranged from 52 to 89 years old, 16 males and 6 females. Causes of airway stenosis were lung cancer in 11 cases, esophageal cancer in 4 cases, thyroid cancer in 3 cases, breast cancer in 2 cases, prostate cancer in 1 case, and mediastinal tumor in 1 case. 13 cases were placed under a rigid endoscope, and 9 cases were placed under a flexible endoscope. Post-treatment was performed in 15 cases, including chemotherapy alone in 7 cases, radiotherapy alone in 5 cases, and chemoradiotherapy in 3 cases. Postoperative dyspnea improved in all patients. Postoperative complications included 2 cases of infection (1 case of cervical abscess, 1 case of pneumonia), 2 cases of prolapse, 2 cases of esophageal obstruction, and 1 case of reintubation after weaning the ventilator after surgery. There were no cases where ECMO was attached, and only sheath insertion was performed in 3 cases. The median survival time for all patients was 79.5 days, with a median survival time of 100 days (36-449 days) in the post-treatment group and 74 days (18-210 days) in the no-treatment group. Long-term survival trended (p=0.064) in the post-treatment group. Conclusion: Although stent treatment for airway stenosis is a palliative treatment, it greatly contributes to QOL improvement. In stenosis caused by malignant tumors, prolongation of survival can be expected by performing post-treatment such as chemotherapy and radiotherapy after stent placement.
- Open Access
- 15 July 2020
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 59 (14) , 1739-1740
Dramatic Response of Brain Metastasis from EGFR-mutation-positive NSCLC to Dacomitinib
The central nervous system efficacy of dacomitinib, a key agent used in the treatment of epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC), is unclear. We herein present our experience in the use of dacomitinib for the treatment of multiple brain metastatic lesions from EGFR-mutation-positive NSCLC in an elderly patient. This case report demonstrates that dacomitinib can be an essential treatment option for patients with brain metastases.
- 15 July 2020
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 59 (14) , 1739-1740
Open AccessDramatic Response of Brain Metastasis from EGFR-mutation-positive NSCLC to Dacomitinib
The central nervous system efficacy of dacomitinib, a key agent used in the treatment of epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC), is unclear. We herein present our experience in the use of dacomitinib for the treatment of multiple brain metastatic lesions from EGFR-mutation-positive NSCLC in an elderly patient. This case report demonstrates that dacomitinib can be an essential treatment option for patients with brain metastases.
- Open Access
- 1 January 2013
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 52 (1) , 97-100
A Definite Case of L-carbocisteine-induced Pneumonia with CATCH22 Syndrome
A 32-year-old male with CATCH22 syndrome presented with a high fever and productive cough after taking drugs for acute bronchitis, including L-carbocisteine. Chest radiography revealed ground-glass opacities in the bilateral lung fields. He had a history of similar pneumonia. Under the assumption of drug-induced pneumonia, or bacterial or viral pneumonia, all drugs including L-carbocisteine were discontinued, and antibiotics were started. A drug-induced lymphocyte stimulation test was positive only for L-carbocisteine. The only drug in common between this and the previous episode of pneumonia was L-carbocisteine. We thus concluded that this was a definite case of L-carbocisteine-induced pneumonia in a patient with CATCH22 syndrome.
- 1 January 2013
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 52 (1) , 97-100
Open AccessA Definite Case of L-carbocisteine-induced Pneumonia with CATCH22 Syndrome
A 32-year-old male with CATCH22 syndrome presented with a high fever and productive cough after taking drugs for acute bronchitis, including L-carbocisteine. Chest radiography revealed ground-glass opacities in the bilateral lung fields. He had a history of similar pneumonia. Under the assumption of drug-induced pneumonia, or bacterial or viral pneumonia, all drugs including L-carbocisteine were discontinued, and antibiotics were started. A drug-induced lymphocyte stimulation test was positive only for L-carbocisteine. The only drug in common between this and the previous episode of pneumonia was L-carbocisteine. We thus concluded that this was a definite case of L-carbocisteine-induced pneumonia in a patient with CATCH22 syndrome.